When you buy through links on our articles, Future and its syndication partners may earn a commission.

Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...

An increase was seen in the detection of invasive cancers and in situ cancers, with a reduction in screen-reading workload.

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

Elon Musk was asked about his ketamine usage in an interview with Don Lemon. The head of DOGE says it's purely for medical ...

WhiteSwell today announced positive data from 21 patients treated in a trial evaluating its eLym system for fluid removal.

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Tuberculosis patients who receive cash incentives and counselling have a 52% lower relative risk of having an unsuccessful ...